Test ID JAK2V JAK2 V617F Mutation Detection, Varies
Useful For
Aiding in the distinction between a reactive blood cytosis and a chronic myeloproliferative disorder using extracted DNA specimens
Special Instructions
Method Name
Quantitative Polymerase Chain Reaction (PCR)
Reporting Name
JAK2 V617F Mutation Detection, VSpecimen Type
VariesSpecimen Required
Specimen Type: Extracted DNA from blood or bone marrow
Container/Tube: 1.5- to 2-mL tube with indication of volume and concentration of the DNA
Specimen Volume: Entire specimen
Collection Instructions: Label specimen as extracted DNA from blood or bone marrow and indicate volume and concentration of the DNA.
Specimen Stability Information: Refrigerated/Ambient
Specimen Minimum Volume
50 microliter at a concentration of 20 ng/microliter
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Varies |
Reference Values
An interpretive report will be provided.
Day(s) Performed
Monday through Saturday
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
81270-JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
JAK2V | JAK2 V617F Mutation Detection, V | 43399-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
39724 | JAK2 Result | 53761-3 |
31160 | JAK2 V617F Mutation Detection, V | 43399-5 |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Report Available
2 to 5 daysNY State Approved
YesForms
1. Hematopathology Patient Information (T676)
2. If not ordering electronically, complete, print, and send a Hematopathology/Cytogenetics Test Request (T726) with the specimen.